BROOKE JANAS: Open Payments
NPI 1578017604 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 25 payments from 15 companies in 2025. Trend: 2023 $693 · 2024 $469 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Lundbeck LLC | 3 | $44 |
| Astellas Pharma US Inc | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Biogen, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| BioWound Solutions, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $19 |
Products named: REXULTI, QULIPTA, CAPLYTA, Veozah, ZURZUVAE, bio-ConneKt, Kerendia, CONTRAVE.
Industry payments across NE — which companies pay providers there.
